Insider Trading › XLRN › Insiders
XLRN
XLRN·Insider activity
—
No end-of-day price on record
XLRN
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
XLRNS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of XLRN were filed in the last 180 days. Newest filing Sep 27, 2021 (5 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by XLRN insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
627Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of XLRN common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
627 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −5,000 | $175.00 | $875K | 18.5Kdirect | Sep 27, 2021 | Sep 27, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −5,370 | $160.38 | $861K | 10.7Kdirect | Sep 24, 2021 | Sep 24, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −983 | $161.26 | $159K | 10.7Kdirect | Sep 23, 2021 | Sep 24, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −18.6K | $160.26 | $3.0M | 11.7Kdirect | Sep 23, 2021 | Sep 24, 2021 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −6,650 | $150.05 | $998K | 18.9Kdirect | Sep 21, 2021 | Sep 22, 2021 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −5,000 | $150.03 | $750K | 18.5Kdirect | Sep 21, 2021 | Sep 22, 2021 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −1,407 | $130.00 | $183K | 18.9Kdirect | Sep 9, 2021 | Sep 9, 2021 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −6 | $130.00 | $780 | 20.3Kdirect | Sep 8, 2021 | Sep 9, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −1,588 | $128.21 | $204K | 98.5Kdirect | Jul 2, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −11.5K | $127.51 | $1.5M | 100.0Kdirect | Jul 2, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −29.1K | $126.69 | $3.7M | 111.5Kdirect | Jul 2, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −9,055 | $128.82 | $1.2M | 98.5Kdirect | Jul 1, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −4,560 | $127.89 | $583K | 107.5Kdirect | Jul 1, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −23.2K | $126.85 | $2.9M | 112.1Kdirect | Jul 1, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −9,194 | $125.81 | $1.2M | 135.2Kdirect | Jul 1, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −11.8K | $125.15 | $1.5M | 144.4Kdirect | Jul 1, 2021 | Jul 2, 2021 | Form 4 ↗ |
| MCCOURT Thomas ADirector | Sale | −200 | $121.23 | $24K | 6,044direct | Apr 19, 2021 | Apr 21, 2021 | Form 4 ↗ |
| MCCOURT Thomas ADirector | Sale | −1,143 | $120.16 | $137K | 6,244direct | Apr 19, 2021 | Apr 21, 2021 | Form 4 ↗ |
| MCCOURT Thomas ADirector | Sale | −4,030 | $119.36 | $481K | 7,387direct | Apr 19, 2021 | Apr 21, 2021 | Form 4 ↗ |
| MCCOURT Thomas ADirector | Sale | −2,127 | $118.39 | $252K | 11.4Kdirect | Apr 19, 2021 | Apr 21, 2021 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −1,100 | $142.27 | $156K | 34.5Kdirect | Apr 5, 2021 | Apr 5, 2021 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −2,152 | $141.28 | $304K | 35.6Kdirect | Apr 5, 2021 | Apr 5, 2021 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −6,748 | $140.31 | $947K | 37.8Kdirect | Apr 5, 2021 | Apr 5, 2021 | Form 4 ↗ |
| Smith Karen L.Director | Sale | −641 | $141.15 | $90K | 1,622direct | Apr 5, 2021 | Apr 5, 2021 | Form 4 ↗ |
| Smith Karen L.Director | Sale | −11.2K | $140.13 | $1.6M | 2,263direct | Apr 5, 2021 | Apr 5, 2021 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −1,600 | $135.67 | $217K | 34.5Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −1,700 | $135.22 | $230K | 36.1Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −6,596 | $134.27 | $886K | 37.8Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −104 | $132.61 | $14K | 44.4Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Smith Karen L.Director | Sale | −941 | $137.92 | $130K | 4,561direct | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Smith Karen L.Director | Sale | −3,796 | $136.92 | $520K | 5,502direct | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Smith Karen L.Director | Sale | −2,987 | $136.22 | $407K | 9,298direct | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Smith Karen L.Director | Sale | −1,201 | $134.54 | $162K | 12.3Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −200 | $138.15 | $28K | 19.4Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −600 | $137.12 | $82K | 19.6Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −1,501 | $136.24 | $204K | 20.2Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −2,699 | $135.48 | $366K | 21.7Kdirect | Mar 2, 2021 | Mar 4, 2021 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −100 | $124.30 | $12K | 16.2Kdirect | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −56 | $122.93 | $7K | 16.3Kdirect | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −1,900 | $122.46 | $233K | 16.3Kdirect | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −4 | $123.50 | $494 | 5,813direct | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −296 | $122.85 | $36K | 5,817direct | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −499 | $121.89 | $61K | 6,113direct | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −700 | $120.43 | $84K | 6,612direct | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −94 | $122.55 | $12K | 81.8Kdirect | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −764 | $122.46 | $94K | 81.9Kdirect | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −900 | $121.55 | $109K | 82.6Kdirect | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −2,500 | $120.52 | $301K | 83.5Kdirect | Jan 5, 2021 | Jan 6, 2021 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −4,624 | $126.15 | $583K | 3,987direct | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −3,429 | $125.17 | $429K | 8,611direct | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −1,947 | $123.90 | $241K | 12.0Kdirect | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −300 | $124.45 | $37K | 7,312direct | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −667 | $124.47 | $83K | 7,612direct | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −600 | $123.49 | $74K | 8,279direct | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −200 | $125.49 | $25K | 8,879direct | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −713 | $124.28 | $89K | 9,079direct | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −800 | $123.54 | $99K | 9,792direct | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −42.5K | $130.14 | $5.5M | 11.2Kdirect | Dec 14, 2020 | Dec 15, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −3,100 | $125.00 | $388K | 11.2Kdirect | Dec 11, 2020 | Dec 11, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −500 | $125.12 | $63K | 11.2Kdirect | Dec 10, 2020 | Dec 11, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −3,872 | $125.03 | $484K | 11.2Kdirect | Dec 9, 2020 | Dec 11, 2020 | Form 4 ↗ |
| Kearney Terrence CDirector | Sale | −913 | $120.57 | $110K | 5,127direct | Oct 12, 2020 | Oct 13, 2020 | Form 4 ↗ |
| Kearney Terrence CDirector | Sale | −16.2K | $119.78 | $1.9M | 6,040direct | Oct 12, 2020 | Oct 13, 2020 | Form 4 ↗ |
| Kearney Terrence CDirector | Sale | −18.2K | $119.11 | $2.2M | 22.3Kdirect | Oct 12, 2020 | Oct 13, 2020 | Form 4 ↗ |
| Kearney Terrence CDirector | Sale | −2,200 | $117.82 | $259K | 40.4Kdirect | Oct 12, 2020 | Oct 13, 2020 | Form 4 ↗ |
| MCCOURT Thomas ADirector | Sale | −200 | $91.38 | $18K | 4,422direct | Sep 11, 2020 | Sep 15, 2020 | Form 4 ↗ |
| MCCOURT Thomas ADirector | Sale | −13.9K | $90.64 | $1.3M | 4,622direct | Sep 11, 2020 | Sep 15, 2020 | Form 4 ↗ |
| MCCOURT Thomas ADirector | Sale | −9,176 | $89.98 | $826K | 18.5Kdirect | Sep 11, 2020 | Sep 15, 2020 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −929 | $89.85 | $83K | 19.2Kdirect | Sep 8, 2020 | Sep 9, 2020 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −1,071 | $89.20 | $96K | 20.1Kdirect | Sep 8, 2020 | Sep 9, 2020 | Form 4 ↗ |
| CELGENE CORP /DE/10% owner | Sale | −2,241 | $102.28 | $229K | 7.0Mdirect | Jul 9, 2020 | Jul 13, 2020 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −1,100 | $99.42 | $109K | 89.3Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −4,400 | $98.57 | $434K | 90.4Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −9,534 | $97.43 | $929K | 94.8Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −15.2K | $96.49 | $1.5M | 104.4Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −13.0K | $95.85 | $1.3M | 119.6Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −3,000 | $94.46 | $283K | 132.6Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −3,700 | $93.53 | $346K | 135.6Kdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| CELGENE CORP /DE/10% owner | Purchase | +108.1K | $92.50 | $10.0M | 7.0Mdirect | Jul 1, 2020 | Jul 6, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −17.2K | $88.19 | $1.5M | 11.2Kdirect | Apr 9, 2020 | Apr 10, 2020 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −417 | $87.53 | $37K | 21.2Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −1,100 | $86.69 | $95K | 21.6Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −2,883 | $85.77 | $247K | 22.7Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −700 | $84.62 | $59K | 25.6Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| Veness Adam MSVP, General Counsel and Sec. | Sale | −900 | $83.49 | $75K | 26.3Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −3,703 | $87.50 | $324K | 11.2Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −5,921 | $86.79 | $514K | 14.9Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −15.4K | $85.80 | $1.3M | 20.8Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −3,803 | $84.89 | $323K | 36.3Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −5,037 | $83.68 | $421K | 40.1Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −2,900 | $82.83 | $240K | 45.1Kdirect | Apr 8, 2020 | Apr 10, 2020 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −5 | $94.82 | $474 | 15.3Kdirect | Feb 13, 2020 | Feb 14, 2020 | Form 4 ↗ |
| KANGO SUJAYEVP, Chief Commercial Officer | Sale | −590 | $94.09 | $56K | 15.3Kdirect | Feb 13, 2020 | Feb 14, 2020 | Form 4 ↗ |
| Veness Adam MVP, General Counsel and Sec. | Sale | −875 | $51.23 | $45K | 14.8Kdirect | Jan 3, 2020 | Jan 3, 2020 | Form 4 ↗ |
| KANGO SUJAYSVP, Chief Commercial Officer | Sale | −11 | $51.27 | $564 | 9,570direct | Jan 3, 2020 | Jan 3, 2020 | Form 4 ↗ |
| KANGO SUJAYSVP, Chief Commercial Officer | Sale | −469 | $51.37 | $24K | 9,581direct | Jan 3, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −3,634 | $51.24 | $186K | 67.2Kdirect | Jan 3, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −98 | $51.26 | $5K | 70.8Kdirect | Jan 3, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Veness Adam MVP, General Counsel and Sec. | Sale | −434 | $52.83 | $23K | 15.7Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Quisel John DEVP, Chief Business Officer | Sale | −4,242 | $52.52 | $223K | 53.3Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Quisel John DEVP, Chief Business Officer | Sale | −1,600 | $52.51 | $84K | 57.6Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,566 | $52.52 | $82K | 4,847direct | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −2,300 | $52.49 | $121K | 6,413direct | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,713 | $52.51 | $90K | 8,713direct | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −11.9K | $50.28 | $596K | 10.4Kdirect | Dec 13, 2019 | Dec 17, 2019 | Form 4 ↗ |
| Veness Adam MVP, General Counsel and Sec. | Sale | −23 | $45.75 | $1K | 16.1Kdirect | Sep 10, 2019 | Sep 10, 2019 | Form 4 ↗ |
| Veness Adam MVP, General Counsel and Sec. | Sale | −801 | $45.18 | $36K | 16.1Kdirect | Sep 10, 2019 | Sep 10, 2019 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −3,389 | $45.24 | $153K | 87.0Kdirect | Sep 10, 2019 | Sep 10, 2019 | Form 4 ↗ |
| Quisel John DEVP, Chief Business Officer | Sale | −3,584 | $45.23 | $162K | 59.2Kdirect | Sep 10, 2019 | Sep 10, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −173 | $45.75 | $8K | 22.3Kdirect | Sep 10, 2019 | Sep 10, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −7,827 | $45.29 | $354K | 22.5Kdirect | Sep 10, 2019 | Sep 10, 2019 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −344 | $45.67 | $16K | 70.9Kdirect | Sep 10, 2019 | Sep 10, 2019 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −5,281 | $45.20 | $239K | 71.2Kdirect | Sep 10, 2019 | Sep 10, 2019 | Form 4 ↗ |
| Veness Adam MVP, General Counsel and Sec. | Sale | −3,268 | $45.00 | $147K | 16.9Kdirect | Aug 9, 2019 | Aug 12, 2019 | Form 4 ↗ |
| Veness Adam MVP, General Counsel and Sec. | Sale | −538 | $40.71 | $22K | 20.2Kdirect | Jul 16, 2019 | Jul 17, 2019 | Form 4 ↗ |
| George JeanDirector | Sale | −11.8K | $41.17 | $486K | 0indirect | Jun 28, 2019 | Jun 28, 2019 | Form 4 ↗ |
| George JeanDirector | Sale | −25.7K | $39.16 | $1.0M | 15.6Kdirect | Jun 26, 2019 | Jun 28, 2019 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Purchase | +5,000 | $38.05 | $190K | 12.8Kdirect | Jun 14, 2019 | Jun 17, 2019 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −70 | $44.24 | $3K | 90.4Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −100 | $45.46 | $5K | 90.4Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −3,452 | $44.62 | $154K | 90.5Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| Quisel John DEVP, CBO and Secretary | Sale | −70 | $44.24 | $3K | 53.8Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| Quisel John DEVP, CBO and Secretary | Sale | −100 | $45.46 | $5K | 53.9Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| Quisel John DEVP, CBO and Secretary | Sale | −3,452 | $44.62 | $154K | 54.0Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −100 | $45.46 | $5K | 30.3Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −11.9K | $44.61 | $531K | 30.4Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −146 | $44.23 | $6K | 76.5Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −100 | $45.46 | $5K | 76.7Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −7,214 | $44.60 | $322K | 76.8Kdirect | Apr 9, 2019 | Apr 11, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −648 | $48.02 | $31K | 42.3Kdirect | Apr 2, 2019 | Apr 4, 2019 | Form 4 ↗ |
| CELGENE CORP /DE/10% owner | Purchase | +706.2K | $43.00 | $30.4M | 6.8Mdirect | Jan 18, 2019 | Jan 22, 2019 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −27 | $40.85 | $1K | 66.3Kdirect | Jan 3, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −1,930 | $43.45 | $84K | 66.3Kdirect | Jan 3, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −374 | $43.94 | $16K | 90.1Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −3,051 | $43.20 | $132K | 90.5Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −2,363 | $42.45 | $100K | 93.6Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Quisel John DEVP, CBO and Secretary | Sale | −475 | $43.92 | $21K | 52.7Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Quisel John DEVP, CBO and Secretary | Sale | −2,558 | $43.10 | $110K | 53.1Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Quisel John DEVP, CBO and Secretary | Sale | −1,300 | $42.31 | $55K | 55.7Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Quisel John DEVP, CBO and Secretary | Sale | −300 | $43.26 | $13K | 57.0Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Quisel John DEVP, CBO and Secretary | Sale | −1,309 | $42.32 | $55K | 57.3Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −97 | $44.06 | $4K | 38.2Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,717 | $43.33 | $74K | 38.3Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −2,186 | $42.56 | $93K | 40.0Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −300 | $43.20 | $13K | 42.2Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,412 | $42.37 | $60K | 42.5Kdirect | Jan 2, 2019 | Jan 4, 2019 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −700 | $54.33 | $38K | 68.2Kdirect | Dec 4, 2018 | Dec 6, 2018 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −5,607 | $53.65 | $301K | 68.9Kdirect | Dec 4, 2018 | Dec 6, 2018 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −3,862 | $52.72 | $204K | 74.5Kdirect | Dec 4, 2018 | Dec 6, 2018 | Form 4 ↗ |
| Dable Habib JCEO and President · Director | Sale | −2,506 | $51.54 | $129K | 78.4Kdirect | Dec 4, 2018 | Dec 6, 2018 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −12.5K | $54.00 | $675K | 43.9Kdirect | Aug 30, 2018 | Aug 31, 2018 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −12.5K | $49.00 | $613K | 43.9Kdirect | Jun 29, 2018 | Jul 3, 2018 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −12.5K | $47.00 | $588K | 56.4Kdirect | Jun 29, 2018 | Jul 3, 2018 | Form 4 ↗ |
| Rovaldi ChristopherSVP, Program Mgmt and Ops | Sale | −600 | $39.02 | $23K | 25.9Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Rovaldi ChristopherSVP, Program Mgmt and Ops | Sale | −2,900 | $38.27 | $111K | 26.5Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −100 | $39.16 | $4K | 95.9Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −1,103 | $38.34 | $42K | 96.0Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Quisel John DSVP, Corp. Dev., GC & Sec. | Sale | −100 | $39.16 | $4K | 56.6Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Quisel John DSVP, Corp. Dev., GC & Sec. | Sale | −1,104 | $38.33 | $42K | 56.7Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −900 | $39.04 | $35K | 68.8Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −3,700 | $38.28 | $142K | 69.7Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −800 | $39.00 | $31K | 43.9Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −3,200 | $38.31 | $123K | 44.7Kdirect | Apr 3, 2018 | Apr 4, 2018 | Form 4 ↗ |
| POPS RICHARD FDirector | Sale | −2,902 | $42.32 | $123K | 31.3Kdirect | Mar 6, 2018 | Mar 8, 2018 | Form 4 ↗ |
| POPS RICHARD FDirector | Sale | −34.6K | $41.34 | $1.4M | 34.2Kdirect | Mar 6, 2018 | Mar 8, 2018 | Form 4 ↗ |
| Rovaldi ChristopherSVP, Program Mgmt and Ops | Sale | −11.0K | $45.00 | $495K | 24.7Kdirect | Jan 12, 2018 | Jan 17, 2018 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −200 | $43.84 | $9K | 42.8Kdirect | Jan 4, 2018 | Jan 4, 2018 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −14.8K | $43.00 | $636K | 43.0Kdirect | Jan 4, 2018 | Jan 4, 2018 | Form 4 ↗ |
| Rovaldi ChristopherSVP, Program Mgmt and Ops | Sale | −833 | $42.45 | $35K | 24.7Kdirect | Jan 3, 2018 | Jan 4, 2018 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −2,033 | $43.33 | $88K | 73.4Kdirect | Jan 3, 2018 | Jan 4, 2018 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −2,300 | $42.40 | $98K | 75.4Kdirect | Jan 3, 2018 | Jan 4, 2018 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −300 | $40.86 | $12K | 77.7Kdirect | Jan 3, 2018 | Jan 4, 2018 | Form 4 ↗ |
| Rovaldi ChristopherSVP, Program Mgmt and Ops | Sale | −1,433 | $42.41 | $61K | 25.5Kdirect | Jan 2, 2018 | Jan 4, 2018 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −4,300 | $42.41 | $182K | 92.7Kdirect | Jan 2, 2018 | Jan 4, 2018 | Form 4 ↗ |
| Quisel John DSVP, Corp. Dev., GC & Sec. | Sale | −4,333 | $42.42 | $184K | 53.0Kdirect | Jan 2, 2018 | Jan 4, 2018 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −4,000 | $42.42 | $170K | 45.3Kdirect | Jan 2, 2018 | Jan 4, 2018 | Form 4 ↗ |
| George JeanDirector | Sale | −105.1K | $35.73 | $3.8M | 0indirect | Dec 15, 2017 | Dec 18, 2017 | Form 4 ↗ |
| CELGENE CORP /DE/10% owner | Purchase | +745.6K | n/c | — | 6.1Mdirect | Sep 25, 2017 | Sep 25, 2017 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −8 | $38.12 | $305 | 90.2Kdirect | Sep 13, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Quisel John DSVP, Corp. Dev., GC & Sec. | Sale | −8 | $38.03 | $304 | 57.3Kdirect | Sep 13, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Rovaldi ChristopherSVP, Program Mgmt and Ops | Sale | −100 | $39.96 | $4K | 27.0Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Rovaldi ChristopherSVP, Program Mgmt and Ops | Sale | −1,165 | $39.30 | $46K | 27.1Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Rovaldi ChristopherSVP, Program Mgmt and Ops | Sale | −12.7K | $38.32 | $488K | 28.2Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −500 | $39.39 | $20K | 90.2Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −4,605 | $38.31 | $176K | 90.7Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Quisel John DSVP, Corp. Dev., GC & Sec. | Sale | −600 | $39.37 | $24K | 57.3Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Quisel John DSVP, Corp. Dev., GC & Sec. | Sale | −4,505 | $38.29 | $172K | 57.9Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −150 | $39.91 | $6K | 78.0Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −1,600 | $39.24 | $63K | 78.2Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −16.6K | $38.32 | $638K | 79.8Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −210 | $39.85 | $8K | 49.3Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,300 | $39.17 | $51K | 49.5Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −14.5K | $38.32 | $555K | 50.8Kdirect | Sep 12, 2017 | Sep 14, 2017 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −13.1K | $35.41 | $463K | 95.3Kdirect | Aug 8, 2017 | Aug 9, 2017 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −937 | $32.00 | $30K | 95.3Kdirect | Jul 5, 2017 | Jul 7, 2017 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −34.4K | $32.00 | $1.1M | 65.3Kdirect | Jul 5, 2017 | Jul 7, 2017 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −16.0K | $32.00 | $512K | 96.4Kdirect | Jul 5, 2017 | Jul 7, 2017 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −1,641 | $27.60 | $45K | 88.4Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −359 | $26.81 | $10K | 90.1Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Quisel John DSVP, Bus. Dev., GC & Secretary | Sale | −1,400 | $27.56 | $39K | 54.5Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Quisel John DSVP, Bus. Dev., GC & Secretary | Sale | −300 | $26.43 | $8K | 55.9Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,300 | $27.63 | $36K | 70.9Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −400 | $26.87 | $11K | 72.2Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −1,600 | $27.62 | $44K | 96.5Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −400 | $26.81 | $11K | 98.1Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Ertel Steven DEVP & Chief Operating Officer | Sale | −1,900 | $27.61 | $52K | 129.1Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Ertel Steven DEVP & Chief Operating Officer | Sale | −600 | $26.92 | $16K | 131.0Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Purchase | +4,000 | $25.50 | $102K | 4,000direct | Dec 30, 2016 | Jan 3, 2017 | Form 4 ↗ |
| MCGUIRE TERRANCEDirector | Sale | −643 | $30.96 | $20K | 747.1Kindirect | Dec 8, 2016 | Dec 9, 2016 | Form 4 ↗ |
| MCGUIRE TERRANCEDirector | Sale | −34.3K | $30.96 | $1.1M | 744.4Kindirect | Dec 8, 2016 | Dec 9, 2016 | Form 4 ↗ |
| George JeanDirector | Sale | −379.5K | $38.05 | $14.4M | 0indirect | Nov 17, 2016 | Nov 18, 2016 | Form 4 ↗ |
| George JeanDirector | Sale | −41.1K | $39.13 | $1.6M | 379.5Kindirect | Nov 17, 2016 | Nov 18, 2016 | Form 4 ↗ |
| George JeanDirector | Sale | −32.9K | $41.39 | $1.4M | 420.6Kindirect | Nov 16, 2016 | Nov 18, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −100.0K | $32.19 | $3.2M | 214.1Kdirect | Nov 9, 2016 | Nov 14, 2016 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −16.8K | $34.14 | $575K | 75.9Kdirect | Oct 10, 2016 | Oct 11, 2016 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −28 | $34.00 | $952 | 75.9Kdirect | Oct 7, 2016 | Oct 11, 2016 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −19.6K | $33.37 | $655K | 75.9Kdirect | Oct 7, 2016 | Oct 11, 2016 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −1,561 | $34.98 | $55K | 75.9Kdirect | Oct 6, 2016 | Oct 11, 2016 | Form 4 ↗ |
| Kumar RavindraSVP & Chief Scientific Officer | Sale | −14.4K | $34.31 | $496K | 77.4Kdirect | Oct 6, 2016 | Oct 11, 2016 | Form 4 ↗ |
| George JeanDirector | Sale | −857.1K | $35.50 | $30.4M | 453.5Kindirect | Sep 30, 2016 | Oct 4, 2016 | Form 4 ↗ |
| Quisel John DSVP, Bus. Dev., GC & Secretary | Sale | −46.0K | $38.05 | $1.7M | 56.2Kdirect | Sep 21, 2016 | Sep 23, 2016 | Form 4 ↗ |
| Quisel John DSVP, Bus. Dev., GC & Secretary | Sale | −21.4K | $32.14 | $689K | 76.2Kdirect | Sep 12, 2016 | Sep 13, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −10.4K | $34.26 | $358K | 119.1Kdirect | Jul 6, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −31.0K | $33.58 | $1.0M | 129.5Kdirect | Jul 6, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Ertel Steven DEVP & Chief Operating Officer | Sale | −500 | $34.13 | $17K | 127.2Kdirect | Jul 5, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Ertel Steven DEVP & Chief Operating Officer | Sale | −3,466 | $32.89 | $114K | 127.7Kdirect | Jul 5, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −2,390 | $34.22 | $82K | 119.1Kdirect | Jul 5, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −28.1K | $33.18 | $933K | 121.5Kdirect | Jul 5, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −20.2K | $34.89 | $705K | 73.6Kdirect | Jul 1, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −5,793 | $34.20 | $198K | 93.8Kdirect | Jul 1, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Ertel Steven DEVP & Chief Operating Officer | Sale | −28.3K | $34.77 | $984K | 127.2Kdirect | Jul 1, 2016 | Jul 6, 2016 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −25.3K | $34.66 | $877K | 57.6Kdirect | Jul 1, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −20.6K | $34.92 | $720K | 119.1Kdirect | Jul 1, 2016 | Jul 6, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −7,396 | $34.18 | $253K | 139.7Kdirect | Jul 1, 2016 | Jul 6, 2016 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −25.3K | $34.00 | $860K | 67.6Kdirect | May 23, 2016 | May 25, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −25.8K | $33.17 | $855K | 124.1Kdirect | May 20, 2016 | May 20, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −37.6K | $33.04 | $1.2M | 124.1Kdirect | May 19, 2016 | May 20, 2016 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −36.6K | $33.04 | $1.2M | 124.1Kdirect | May 18, 2016 | May 20, 2016 | Form 4 ↗ |
| Ertel Steven DEVP & Chief Operating Officer | Sale | −32.3K | $32.00 | $1.0M | 127.2Kdirect | Apr 7, 2016 | Apr 8, 2016 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −23.9K | $32.00 | $765K | 85.6Kdirect | Apr 7, 2016 | Apr 8, 2016 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −2,080 | $32.00 | $67K | 95.5Kdirect | Apr 6, 2016 | Apr 8, 2016 | Form 4 ↗ |
| CELGENE CORP /DE/10% owner | Purchase | +800.0K | n/c | — | 5.4Mdirect | Jan 11, 2016 | Jan 11, 2016 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −500 | $23.94 | $12K | 8,500indirect | Oct 15, 2015 | Oct 16, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −700 | $22.69 | $16K | 9,000indirect | Oct 15, 2015 | Oct 16, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −2,400 | $23.93 | $57K | 91.6Kdirect | Oct 15, 2015 | Oct 16, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −2,400 | $22.66 | $54K | 94.0Kdirect | Oct 15, 2015 | Oct 16, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −3,460 | $24.64 | $85K | 80.0Kdirect | Oct 7, 2015 | Oct 9, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −3,540 | $24.12 | $85K | 83.5Kdirect | Oct 7, 2015 | Oct 9, 2015 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −12.5K | $24.58 | $306K | 119.1Kdirect | Oct 7, 2015 | Oct 9, 2015 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −6,548 | $24.01 | $157K | 131.5Kdirect | Oct 7, 2015 | Oct 9, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −400 | $34.96 | $14K | 9,700indirect | Sep 16, 2015 | Sep 18, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −200 | $34.93 | $7K | 96.4Kdirect | Sep 16, 2015 | Sep 18, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −300 | $33.55 | $10K | 96.6Kdirect | Sep 16, 2015 | Sep 18, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −1,100 | $32.22 | $35K | 96.9Kdirect | Sep 16, 2015 | Sep 18, 2015 | Form 4 ↗ |
| Ertel Steven DEVP & Chief Operating Officer | Sale | −2,000 | $33.61 | $67K | 119.7Kdirect | Sep 15, 2015 | Sep 16, 2015 | Form 4 ↗ |
| Kumar RavindraVP & Chief Scientific Officer | Sale | −33.0K | $35.00 | $1.2M | 56.7Kdirect | Sep 15, 2015 | Sep 16, 2015 | Form 4 ↗ |
| Quisel John DSVP Gen. Counsel & Secretary | Sale | −1,400 | $34.17 | $48K | 76.1Kdirect | Sep 14, 2015 | Sep 16, 2015 | Form 4 ↗ |
| Quisel John DSVP Gen. Counsel & Secretary | Sale | −4,100 | $33.07 | $136K | 77.5Kdirect | Sep 14, 2015 | Sep 16, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −176 | $31.16 | $5K | 40.0Kdirect | Sep 8, 2015 | Sep 10, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −724 | $30.45 | $22K | 40.2Kdirect | Sep 8, 2015 | Sep 10, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −600 | $29.39 | $18K | 40.9Kdirect | Sep 8, 2015 | Sep 10, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,293 | $31.07 | $40K | 40.0Kdirect | Sep 8, 2015 | Sep 10, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −2,500 | $30.22 | $76K | 41.3Kdirect | Sep 8, 2015 | Sep 10, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,207 | $29.11 | $35K | 43.8Kdirect | Sep 8, 2015 | Sep 10, 2015 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −5,173 | $31.06 | $161K | 21.6Kdirect | Sep 8, 2015 | Sep 10, 2015 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −9,028 | $30.27 | $273K | 26.8Kdirect | Sep 8, 2015 | Sep 10, 2015 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −4,799 | $29.16 | $140K | 35.8Kdirect | Sep 8, 2015 | Sep 10, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −200 | $31.69 | $6K | 10.1Kindirect | Aug 18, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −800 | $30.99 | $25K | 10.3Kindirect | Aug 18, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −400 | $31.95 | $13K | 11.1Kindirect | Aug 18, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −200 | $31.69 | $6K | 32.0Kdirect | Aug 18, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −1,400 | $31.00 | $43K | 32.2Kdirect | Aug 18, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −1,210 | $31.60 | $38K | 32.0Kdirect | Aug 18, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −2,790 | $30.83 | $86K | 33.2Kdirect | Aug 18, 2015 | Aug 19, 2015 | Form 4 ↗ |
| MCGUIRE TERRANCEDirector | Sale Amended | −407.3K | $30.25 | $12.3M | 1.3Mindirect | Aug 17, 2015 | Aug 26, 2015 | Form 4 ↗ |
| Ertel Steven DEVP & Chief Operating Officer | Sale | −2,000 | $30.46 | $61K | 57.7Kdirect | Aug 17, 2015 | Aug 19, 2015 | Form 4 ↗ |
| MCGUIRE TERRANCEDirector | Sale | −407.3K | $30.25 | $12.3M | 1.3Mindirect | Aug 17, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Quisel John DSVP Gen. Counsel & Secretary | Sale | −2,200 | $31.74 | $70K | 36.1Kdirect | Aug 14, 2015 | Aug 17, 2015 | Form 4 ↗ |
| Quisel John DSVP Gen. Counsel & Secretary | Sale | −3,300 | $30.22 | $100K | 38.3Kdirect | Aug 14, 2015 | Aug 17, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,500 | $28.54 | $43K | 40.0Kdirect | Aug 10, 2015 | Aug 12, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −100 | $29.23 | $3K | 40.0Kdirect | Aug 10, 2015 | Aug 12, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −4,900 | $28.51 | $140K | 40.1Kdirect | Aug 10, 2015 | Aug 12, 2015 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −500 | $29.22 | $15K | 21.6Kdirect | Aug 10, 2015 | Aug 12, 2015 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −18.5K | $28.51 | $527K | 22.1Kdirect | Aug 10, 2015 | Aug 12, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −200 | $33.22 | $7K | 11.5Kindirect | Jul 20, 2015 | Jul 21, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −1,000 | $32.31 | $32K | 11.7Kindirect | Jul 20, 2015 | Jul 21, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −800 | $33.22 | $27K | 32.0Kdirect | Jul 20, 2015 | Jul 21, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −100 | $32.74 | $3K | 32.0Kdirect | Jul 20, 2015 | Jul 21, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −3,900 | $32.29 | $126K | 32.1Kdirect | Jul 20, 2015 | Jul 21, 2015 | Form 4 ↗ |
| Ertel Steven DEVP & Chief Operating Officer | Sale | −2,000 | $31.38 | $63K | 57.7Kdirect | Jul 15, 2015 | Jul 17, 2015 | Form 4 ↗ |
| Quisel John DSVP Gen. Counsel & Secretary | Sale | −5,500 | $30.00 | $165K | 22.7Kdirect | Jul 14, 2015 | Jul 16, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −95 | $30.39 | $3K | 35.0Kdirect | Jul 7, 2015 | Jul 9, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −1,905 | $29.68 | $57K | 35.1Kdirect | Jul 7, 2015 | Jul 9, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −377 | $30.27 | $11K | 35.0Kdirect | Jul 7, 2015 | Jul 9, 2015 | Form 4 ↗ |
| MCLAUGHLIN KEVIN FSVP, CFO and Treasurer | Sale | −4,623 | $29.65 | $137K | 35.4Kdirect | Jul 7, 2015 | Jul 9, 2015 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −1,400 | $30.25 | $42K | 17.6Kdirect | Jul 7, 2015 | Jul 9, 2015 | Form 4 ↗ |
| Knopf John LCEO and President · Director | Sale | −17.6K | $29.66 | $522K | 19.0Kdirect | Jul 7, 2015 | Jul 9, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −400 | $31.07 | $12K | 12.7Kindirect | Jun 18, 2015 | Jun 19, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −1,000 | $31.57 | $32K | 13.1Kindirect | Jun 18, 2015 | Jun 19, 2015 | Form 4 ↗ |
| Sherman Matthew LEVP & Chief Medical Officer | Sale | −5,600 | $31.57 | $177K | 32.0Kdirect | Jun 18, 2015 | Jun 19, 2015 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →